Cite Filings / PLSE / 0000950170-24-138214

Feed Companies Filings Check

Sign in

SCHEDULE 13D/A

Beneficial Ownership Report

PULSE BIOSCIENCES, INC. Filed 2024-12-19 Acc 0000950170-24-138214

Documents 1

SCHEDULE 13D/A Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

2026-05-13 SCHEDULE 13D/A Beneficial Ownership Report
2024-12-20 4 Former President and CEO sold 50,000 shares at $17.42 ($871,000)
2024-12-19 SCHEDULE 13D/A Beneficial Ownership Report
2024-12-18 4 Director acquired 5,306,156 shares (option exercise)
2024-12-17 4 Director bought 55,256 shares at $17.18 ($949,298)
2024-12-17 4 Director bought 45,404 shares at $17.13 ($777,771)
2024-12-13 4 Director bought 56,054 shares at an average $17.35 ($972,344)

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…